300016 Share Price Performance
CN¥10.02
4.20 (72.16%)
Price CN¥10.02
Share Pricen/a
Beijing Beilu Pharmaceutical Co., Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
300016 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Beijing Beilu Pharmaceutical Co., Ltd. Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Apr 22, 2026
- 0.059
- 43.87%
- 2.97%
- 20.7%
About 300016
- Founded
- 1992
- Employees
- 1173
- CEO
- WebsiteView website
Beijing Beilu Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products in China. The company provides contrast agents, such as gadopentetate meglumine injection, gadobutrol injection, and gadobenate meglumine injection for MRI contrast; and iohexol injection, iopamidol injection, and iodixanol injection for CT contrast, as well as glimepiride and repaglinide tablets and jiuwei zhenxin granules. It also offers gadolinium-based agents, including gadopentetate dimeglumine and gadobutrol, as well as iodine-based agents comprising iohexol, ioversol, iodixanol, iopromide, and iopamidol, as well as oral anti-diabetic drugs. The company was founded in 1992 and is based in Beijing, China.
